LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) named three members to its Scientific Advisory Board (SAB), which was established earlier this year under the leadership of Associate Dean for Research at Virginia Commonwealth University School of Medicine Dr. Gordon Archer.
